Clinical Trials Browser

Recurrence × Immunotherapy, Adoptive × CNS × Clear all

NCT03423992 2021-06-15

Personalized Chimeric Antigen Receptor T Cell Immunotherapy for Patients With Recurrent Malignant Gliomas

Phase 1 Unknown

Glioma, Recurrence